Alnylam Pharmaceuticals competitors and similar companiesClear all

Alnylam Pharmaceuticals's competitors and similar companies include Reata Pharmaceuticals, Celyad, Sorrento Therapeutics, Moderna, CureVac, Regulus Therapeutics, Sarepta Therapeutics and Ionis Pharmaceuticals.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Sorrento Therapeutics
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Moderna
Moderna
Moderna is a biotechnology company that develops therapeutics and vaccines.
CureVac
CureVac
CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Founding Date
Founding Date
2002
Founding Date
2002
Founding Date
2007
Founding Date
2006
Founding Date
2010
Founding Date
2000
Founding Date
2007
Founding Date
1980
Founding Date
1989
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Locations
Plano, US HQ
Irving, US
Plano, US
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
San Diego, US HQ
San Diego, US
Locations
Cambridge, US HQ
Norwood, US
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
Tübingen, DE
Boston, US
Locations
San Diego, US HQ
Locations
Cambridge, US HQ
Dublin, IE
Zug, CH
Providence, US
Locations
Carlsbad, US HQ
Employees
Employees
1,32324% increase
Employees
22079% increase
Employees
95
Employees
31019% decrease
Employees
2,700108% increase
Employees
4004% increase
Employees
2462% decrease
Employees
8403% decrease
Employees
7577% decrease
Valuation ($)
Valuation ($)
27.7 b
Valuation ($)
1.4 b
Valuation ($)
28.3 m
Valuation ($)
309.4 m
Valuation ($)
78.3 b
Valuation ($)
1.5 b
Valuation ($)
223.3 m
Valuation ($)
10.7 b
Valuation ($)
5.6 b
Twitter followers
Twitter followers
16 k
Twitter followers
1.3 k
Twitter followers
2.4 k
Twitter followers
N/A
Twitter followers
151 k
Twitter followers
10
Twitter followers
808
Twitter followers
4.6 k
Twitter followers
4.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
27
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
30
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
9.1
Average likes per tweet (last 30 days)
2.3
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
33.3
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
10.1
Average likes per tweet (last 30 days)
6.4
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
71.43%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
376993
Alexa Website Rank
267230
Alexa Website Rank
460272
Alexa Website Rank
412753
Alexa Website Rank
288967
Alexa Website Rank
457967
Alexa Website Rank
181560
Alexa Website Rank
448530
Alexa Website Rank
333062
Employee Rating
Employee Rating
4.2
Employee Rating
3.6
Employee Rating
3.5
Employee Rating
3.4
Employee Rating
3.7
Employee Rating
3.2
Employee Rating
2.8
Employee Rating
4.1
Employee Rating
3.6

Financial

Revenue (est.)
Revenue (est.)
$844.3m (FY, 2021)
Revenue (est.)
$11.5m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
$52.9m (FY, 2021)
Revenue (est.)
$18.5b (FY, 2021)
Revenue (est.)
€12.6m (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$701.9m (FY, 2021)
Revenue (est.)
$810.5m (FY, 2021)
Cost of goods
Cost of goods
$115m (FY, 2021)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$2.6b (FY, 2021)
Cost of goods
€22.3m (FY, 2018)
Cost of goods
N/A
Cost of goods
$97m (FY, 2021)
Cost of goods
$10.8m (FY, 2021)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
€5.8m (FY, 2021)
Gross profit
N/A
Gross profit
$15.9b (FY, 2021)
Gross profit
(€9.8m) (FY, 2018)
Gross profit
N/A
Gross profit
$604.8m (FY, 2021)
Gross profit
N/A
Net income
Net income
($852.8m) (FY, 2021)
Net income
($297.4m) (FY, 2021)
Net income
(€26.5m) (FY, 2021)
Net income
($429.1m) (FY, 2021)
Net income
$12.2b (FY, 2021)
Net income
(€74.6m) (FY, 2018)
Net income
($27.8m) (FY, 2021)
Net income
($418.8m) (FY, 2021)
Net income
($28.6m) (FY, 2021)

Operating

Patent Applications
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
430 (FY, 2021)
Patent Applications
500 (Mar, 2020)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
170 (FY, 2021)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
161 (Jun, 2021)
Patents Issued
Patents Issued
N/A
Patents Issued
240 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
270 (FY, 2020)
Patents Issued
233 (May, 2020)
Patents Issued
300 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
3 (May, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
6 (FY, 2020)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
24 (FY, 2020)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
6 (FY, 2020)

Funding

Total funding raised
Total funding raised
$ 1.5b
Total funding raised
$ 468.9m
Total funding raised
N/A
Total funding raised
$ 42.6m
Total funding raised
$ 1.8b
Total funding raised
$ 1.1b
Total funding raised
$ 10m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Reata Pharmaceuticals
HQ
Plano, US
Employees
220

Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.

View company
Celyad
HQ
Mont-Saint-Guibert, BE
Employees
95

Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.

View company
Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

View company
Moderna
HQ
Cambridge, US
Employees
2,700

Moderna is a biotechnology company that develops therapeutics and vaccines.

View company